Type of Article:  Original Research

Volume 7; Issue 3.2 (August 2019)

Page No.: 6793-6799

DOI: https://dx.doi.org/10.16965/ijar.2019.227


Vinay Kumar .V.

Professor, Department of Anatomy, K.S. Hegde Medical Academy, Nitte (Deemed to be University), Deralakatte, Mangaluru, Karnataka, India.

Address for Correspondence:  Dr. Vinay Kumar .V, Professor, Department of Anatomy, K.S. Hegde Medical Academy, Nitte (Deemed to be University), Deralakatte, Mangaluru, Karnataka, India.  Ph: +917795767676. E-Mail: dr7795767676@gmail.com


Background: Head and neck cancer (HNC) represents 3% of all the malignant tumours. It is the sixth most common human malignancy. Patients with head and neck cancer receiving radiotherapy are exposed to ionizing radiation which may damage normal tissue located in the field of radiation. The present study aims to determine the changes in antioxidants status of pre and post RT saliva samples of HNC patients

Materials and Methods: The pre and post radiotherapy saliva samples were collected from every patient with head and neck cancer. The changes in the antioxidant levels of saliva in pre and post radiotherapy saliva samples of head and neck cancer patients was determined.

Observation: The three biochemical parameters levels Malondealdehyde, Glutathione peroxidase, Myeloperoxidase decreased following radiotherapy. But the decrease was not statistically significant for Glutathione peroxidase and Myeloperoxidase and highly significant for Malondealdehyde.

Conclusion: The Total Antioxidant Capacity increased following radiotherapy and it was observed that after radiotherapy their increased levels were statistically not significant.

Key words: Saliva, Antioxidants, Radiotherapy, Head and neck cancer.


  1. Mitra D, Malkoski SP, Wang XJ. Cancer stem cells in head and neck cancer. Cancers (Basel) 2011;3:415-427.
  2. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. 2008;371:1695-1709.
  3. Jemal A, Center MM, Ward E, Thun MJ. Cancer occurrence. Methods Mol Biol. 2009;471:3-29.
  4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN. 2008. Int J Cancer. 2010;127:2893-2917.
  5. Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. 2010;15:994-1001.
  6. Dobbs J, Barret A, Ash D. Practical radiotherpy planing. 3rd Ed, London, Arnold: Oxford university press; 1999.
  7. Handshel J, Prott FJ, Sunderkotte C, Metze D, Meyer U, Joos U. Irradiation induces increase of adhesion molecules and accumulation of beta2 integrin expressing cells in humans. Int J Radiat Onco Biol Phys. 1999;45:475-81.
  8. Taylor SE, Miller EG. Preemptive pharmacologic intervention in the radiation induced salivary dysfunction. Proc Soc Exp Biol Med. 1999;221:1426.
  9. Nagler RM. The enigmatic mechanisms of irradiation induced damage to major salivary glands. Oral Dis. 2002;8:1416.
  10. Spielman AI. Chemosensory function and dysfunction. Crit Rev Oral Bio Med. 1998;9:267-91.
  11. Anneroth G, Holm LE, Karlsson G. The effect of radiation on teeth: A clinical, histological, and microradiographic study. Int J oral Surgey. 1985;14:269-74.
  12. Steel CG. Basic clinical radiobiology. 3rd edition, London, Arnold: Oxford university press; 2002:231-40.
  13. Hall EJ. Radiobiology for the radiobiologist. 5 th Ed, Philadelphia: Lippincoat Willams and Wilkins; 2000:453-6.
  14. Yosuf ZW, Bakri MM. Severe progressive periodontal destruction due to radiation tissue injury. J Periodontol. 1993;64:125-38.
  15. Epstein JB, Lunn R, Le N, StevensonMooreP. Periodontal attachment loss in patients after head and neck radiation therapy. Oral Surg Oral Med Oral Pathol Endod. 1998;86:673-7.
  16. Engels H, Wambersie A. Relative biological effectiveness of neutrons for cancer induction and other late effects: a review of biological data recent. Recent Results Cancer Res. 1998;150:54-87.
  17. Kaiser HE, Nasir A, Groger A, M., Link, C., J., Jr. The etiology of second primary neoplasms. In vivo. 1998;12:89-93.
  18. Perel Y, Leverger G, Carrere A, Caudry M, Garabedian EN, Ansoborlo S, Vergnes P. Second thyroid neoplasms after prophylactic cranial irradiation for acute lymphoblastic leukemia. Am J. Hamatol. 1998;59:91-94.
  19. Prieto P, Manuel P, Miguel A. Spectrophotometric quantitation of antioxidant capacity through the formation of phosphomolybdenum complex: specific application to the determination of vitamin E. Analytical biochemistry. 1999;269(1):337-341.
  20. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-10.
  21. Rotruck, JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG & Hoekstra WG. Selenium: Biochemical role as a component of Glutathione peroxidase, purification and assay. Science, Biochemical methods, 3rd Sadasivan S, Manickam A. 1973;179:588-598.
  22. Malheston N R, Wong PS, Travis J. Biochem. Enzymatic inactivation of human alpha 1 proteinase inhibitor by neutrophil myeloperoxidase. 1982;20:325-330.
  23. Fenech M, Morley AA. Measurements of micronuclei in lymphocytes. Mutat. Res. 1985;147:29-36.
  24. Casartelli G, Bonatti S, De Ferrari M, Scala M, Mereu P, Margarino G, et al. Micronucleus
  25. frequencies in exfoliated buccal cells in normal mucosa, precancerous lesions and squamous cell carcinoma. Anal Quant Cytol Histol. 2000;22:486-92.
  26. Stich HF, San RH, Rosin MP. Adaptation of the DNA repair and micronucleus tests to human cell suspensions and exfoliated cells. Ann N Y Acad Sci.1983;407:93-105.
  27. Sarto F, Finotto S, Giacomelli L, Mazzotti D, Tomanin R, Levis AG. The micronucleus assay in exfoliated cells of the human buccal mucosa. Mutagenesis. 1987;2:11-17.
  28. Tolbert PE, Shy CM, Allen JW. Micronuclei and other nuclear anomalies in buccal smears: A field test in snuff users. Am J Epidemiol 1991;134:84050.
  29. Moore LE, Warner ML, Smith AH, Kalman D, Smith MT. Use of the fluorescent micronucleus assay to detect the genotoxic effects of radiation and arsenic exposure in exfoliated human epithelial cells. Environ Mol Mutagen. 1996;27:176-84.
  30. Bina K, Padala SR. Micronuclei assay of exfoliated oral buccal cells: Means to assess the nuclear abnormalities in different diseases. Journal of Cancer Research and Therapeutics. 2012;8(2):184-191.
  31. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol. 2001; 54: 356-61.
  32. Hershkovich O, Shafat I, Nagler RM. Age related changes in salivary antioxidant profile: Possible implications for oral cancer. J Gerontol A Biol Sci Med Sci. 2007. 62: 361-366.
  33. Soheila M, Farid A, Iraj MD, Roya K, Mostafa E, Afshin A. Alteration of Lipid Peroxidation and Total Antioxidant Capacity in Patients With Head and Neck Cancers Following Radiotherapy. J Arch Mil Med. 2015; 3(4): e30431.
  34. Malathi M, Vijay M, Shivashankara AR. The role of oxidative stress and the efect of radiotherapy on the plasma oxidantantioxidant status in head and neck cancer. J Clin Diagnos Res. 2011; 5(2): 249–51.
  35. Rubio et al., Spectrophotometric assays for total antioxidant capacity (TAC) in dog serum: an update. BMC Veterinary Research, 2016; 12: 166.
  36. Hochstein P, Jain SK. Association of lipid peroxidation and polymerization of membrane proteins with erythrocytes ageing. Feed Prodct, 1981; 40: 183-87.
  37. Nielsen H. Covalent binding of peroxidized phospholipids to protein: Reaction of individual phospholipids with different proteins. 1981; 16: 21-25.
  38. Mukai RH. Goldstein BD. Mutagenecity of malondialdehyde: A decomposition product of polysaturated fatty acids. Science.1976; 9: 86-88.
  39. Lobo, Aswin DA. Effect of radiation therapy on lipid peroxidation and total antioxidant capacity of blood and saliva in oral cancer patients. Proceedings of the thirty third annual conference of Indian Association of Biomedical Scientists and international symposium. 2012; 44: 15.
  40. Mahendra RP, Mody RN. Estimation of Serum Malondialdehyde before and after Radiotherapy in Oral Squamous Cell Carcinoma Patients Undergoing Antioxidant Therapy. Journal of Indian Academy of Oral Medicine and Radiology. 2011; 23(4): 563-568.
  41. Arthur JR. The glutathione peroxidases. Cell Mol Life Sci. 2000; 57: 1825–1835.
  42. Meyer M, Pahl HL, Baeuerle PA. Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem Biol Interact. 1994; 91: 91–100.
  43. Yu BP, Chung HY. Adaptive mechanisms to oxidative stress during aging. Mech Ageing Dev. 2006; 127: 436–443.
  44. Manasaveena V, Krishna KA, Sangram V. A comparative evaluation of enzymatic antioxidant levels in pre and post therapy patients with oral cancer. International Journal of Pharmacy and Pharmaceutical Sciences. 2014; 6 (11): 52-56.
  45. Demirci S, Ozsaran Z, Celik HA, Aras AB, Aydin HH. The interaction between antioxidant status and cervical cancer: a case control study. Tumori. 2011; 97: 290–5.
  46. Lai WM, Chen CC, Lee JH, Chen CJ, Wang JS, Hou YY, et al. Second primary tumors and myeloperoxidase expression in buccal mucosal squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 116: 464-73.

Cite this article: Vinay Kumar. V. SALIVARY ANTIOXIDANT STATUS FOLLOWING RADIOTHERAPY IN PATIENTS WITH HEAD AND NECK CANCER. Int J Anat Res 2019;7(3.2):6793-6799. DOI: 10.16965/ijar.2019.227